Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 11, 2023

SELL
$22.53 - $30.98 $239,696 - $329,596
-10,639 Reduced 34.82%
19,917 $509,000
Q4 2022

Feb 14, 2023

SELL
$19.88 - $27.37 $206,612 - $284,456
-10,393 Reduced 25.38%
30,556 $826,000
Q3 2022

Nov 14, 2022

SELL
$21.56 - $29.59 $482,210 - $661,809
-22,366 Reduced 35.32%
40,949 $892,000
Q4 2021

Feb 14, 2022

SELL
$29.25 - $36.02 $212,296 - $261,433
-7,258 Reduced 10.28%
63,315 $2.2 Million
Q3 2021

Nov 15, 2021

BUY
$31.2 - $38.5 $869,762 - $1.07 Million
27,877 Added 65.29%
70,573 $2.2 Million
Q2 2021

Aug 11, 2021

BUY
$36.37 - $45.72 $1.55 Million - $1.95 Million
42,696 New
42,696 $1.55 Million

Others Institutions Holding AVNS

About AVANOS MEDICAL, INC.


  • Ticker AVNS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 46,487,000
  • Market Cap $865M
  • Description
  • Avanos Medical, Inc., a medical technology company, focuses on delivering medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, ...
More about AVNS
Track This Portfolio

Track Susquehanna Fundamental Investments, LLC Portfolio

Follow Susquehanna Fundamental Investments, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna Fundamental Investments, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna Fundamental Investments, LLC with notifications on news.